NCT00300430
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
See it on ClinicalTrials.gov ↗2,201 people
50.9%
49.1%
1,120 womenmiddle line = equal numbers1,081 men
- Phase
- PHASE3
- Paid for by
- Abbott
- Finished
- —
- Health conditions
- Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 55.0 years
- Age 65+
- 18.1%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.